Phreesia PE Ratio 2019-2025 | PHR
Current and historical p/e ratio for Phreesia (PHR) from 2019 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Phreesia PE ratio as of August 22, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Phreesia PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-08-22 | 29.75 | 0.00 | |
| 2025-04-30 | 24.96 | $-0.74 | 0.00 |
| 2025-01-31 | 28.46 | $-1.02 | 0.00 |
| 2024-10-31 | 18.29 | $-1.47 | 0.00 |
| 2024-07-31 | 24.95 | $-1.80 | 0.00 |
| 2024-04-30 | 20.74 | $-2.17 | 0.00 |
| 2024-01-31 | 25.48 | $-2.52 | 0.00 |
| 2023-10-31 | 13.66 | $-2.68 | 0.00 |
| 2023-07-31 | 31.72 | $-2.86 | 0.00 |
| 2023-04-30 | 31.64 | $-3.07 | 0.00 |
| 2023-01-31 | 37.49 | $-3.36 | 0.00 |
| 2022-10-31 | 27.32 | $-3.54 | 0.00 |
| 2022-07-31 | 23.49 | $-3.49 | 0.00 |
| 2022-04-30 | 22.88 | $-3.08 | 0.00 |
| 2022-01-31 | 31.19 | $-2.33 | 0.00 |
| 2021-10-31 | 70.54 | $-1.61 | 0.00 |
| 2021-07-31 | 68.35 | $-1.07 | 0.00 |
| 2021-04-30 | 51.75 | $-0.76 | 0.00 |
| 2021-01-31 | 65.29 | $-0.68 | 0.00 |
| 2020-10-31 | 36.97 | $-0.60 | 0.00 |
| 2020-07-31 | 30.06 | $-0.50 | 0.00 |
| 2020-04-30 | 25.39 | $-10.75 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.770B | $0.420B |
| Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.530B | 60.47 |
| Tempus AI (TEM) | United States | $13.989B | 0.00 |
| Doximity (DOCS) | United States | $12.688B | 56.45 |
| Hims & Hers Health (HIMS) | United States | $10.074B | 82.54 |
| IRhythm Technologies (IRTC) | United States | $5.433B | 0.00 |
| Hinge Health (HNGE) | United States | $4.516B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.839B | 41.74 |
| Privia Health (PRVA) | United States | $2.699B | 199.91 |
| Heartflow (HTFL) | $2.367B | 0.00 | |
| Enovis (ENOV) | United States | $1.797B | 9.50 |
| 10x Genomics (TXG) | United States | $1.780B | 0.00 |
| Omnicell (OMCL) | United States | $1.544B | 29.75 |
| Schrodinger (SDGR) | United States | $1.495B | 0.00 |
| Azenta (AZTA) | United States | $1.446B | 63.10 |
| Clover Health Investments (CLOV) | United States | $1.399B | 0.00 |
| Claritev (CTEV) | United States | $1.189B | 0.00 |
| Evolent Health (EVH) | United States | $1.128B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.666B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.580B | 0.00 |
| Veradigm (MDRX) | United States | $0.525B | 0.00 |
| Standard BioTools (LAB) | United States | $0.485B | 0.00 |
| Talkspace (TALK) | United States | $0.469B | 140.00 |
| Butterfly Network (BFLY) | United States | $0.383B | 0.00 |
| Carlsmed (CARL) | United States | $0.346B | 0.00 |
| TruBridge (TBRG) | United States | $0.307B | 53.90 |
| Outset Medical (OM) | United States | $0.252B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.244B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.231B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.219B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.203B | 0.00 |
| CapsoVision (CV) | United States | $0.187B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.156B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.148B | 0.00 |
| CareCloud (CCLD) | United States | $0.120B | 5.44 |
| American Well (AMWL) | United States | $0.115B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.097B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.074B | 0.00 |
| Pulmonx (LUNG) | United States | $0.069B | 0.00 |
| 111 (YI) | China | $0.060B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| HeartBeam (BEAT) | United States | $0.038B | 0.00 |
| Precipio (PRPO) | United States | $0.023B | 0.00 |
| Zhongchao (ZCMD) | China | $0.022B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.017B | 0.00 |
| PROFUSA (PFSA) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.005B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |